News Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
News Roswell Park-led Team Finds New Evidence Why Some Targeted Therapies Support Better Response to Cancer Immunotherapy
Video First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park
News Roswell Park Clinical Trials Offer Novel Immunotherapies for Advanced/Metastatic Tumors, Refractory Melanoma
News Study Compiling Outcomes of 17,000 Cancer Patients Highlights Need for Careful Treatment Planning, Monitoring
News Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program
News Roswell Park Will Lead $13.5M Effort to Understand Racial Disparities in Response to Immune Checkpoint Inhibitors